UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Wnt/PCP controls spreading of Wnt/β-catenin signals by cytonemes in vertebrates

eLife, 2018-07, Vol.7

2018

Volltextzugriff (PDF)

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Nature biotechnology, 2010-05, Vol.28 (5), p.455-462

2010

Volltextzugriff (PDF)

CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms

Clinical cancer research, 2007-09, Vol.13 (18), p.5556s-5563s

2007

Volltextzugriff (PDF)

Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist

ChemMedChem, 2017-02, Vol.12 (3), p.197-201

2017

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists

ChemMedChem, 2016-12, Vol.11 (24), p.2640-2648

2016

Volltextzugriff (PDF)

Cure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate

Clinical cancer research, 2003-12, Vol.9 (17), p.6567-6571

2003

Volltextzugriff (PDF)

Therapy of Small Subcutaneous B-Lymphoma Xenografts with Antibodies Conjugated to Radionuclides Emitting Low-Energy Electrons

Clinical cancer research, 2005-01, Vol.11 (2), p.777-786

2005

Volltextzugriff (PDF)

α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Antagonists: From Bench to Bedside

Journal of medicinal chemistry, 2010-08, Vol.53 (15), p.5367-5382

2010

Volltextzugriff (PDF)

Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity

Bioorganic & medicinal chemistry letters, 2011-06, Vol.21 (11), p.3358-3361

2011

Volltextzugriff (PDF)

6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (2), p.996-999

2012

Volltextzugriff (PDF)

Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

ChemMedChem, 2010-10, Vol.5 (10), p.1693-1696

2010

Volltextzugriff (PDF)

Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons

European journal of nuclear medicine and molecular imaging, 2008-07, Vol.35 (7), p.1249-1258

2008

Volltextzugriff (PDF)

Improved iodine radiolabels for monoclonal antibody therapy

Cancer research (Chicago, Ill.), 2003, Vol.63 (1), p.111-118

2003

Volltextzugriff (PDF)

Therapy of Advanced B-Lymphoma Xenografts with a Combination of 90Y-anti-CD22 IgG (Epratuzumab) and Unlabeled Anti-CD20 IgG (Veltuzumab)

Clinical cancer research, 2008-10, Vol.14 (19), p.6154-6160

2008

Volltextzugriff (PDF)

Adefovir dipivoxil: A new antiviral agent for the treatment of hepatitis B virus infection

Clinical therapeutics, 2003-12, Vol.25 (12), p.3084-3099

2003

Volltextzugriff (PDF)

Enhancement of Tumor-to-Nontumor Localization Ratios by Hepatocyte-Directed Blood Clearance of Antibodies Labeled with Certain Residualizing Radiolabels

The Journal of nuclear medicine (1978), 1999-08, Vol.40 (8), p.1392-1401

1999

Volltextzugriff (PDF)

Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations

Cancer Immunology, Immunotherapy, 1998-03, Vol.46 (1), p.25-33

1998

Volltextzugriff (PDF)

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22

Cancer Immunology, Immunotherapy, 1997-05, Vol.44 (3), p.179-188

1997

Volltextzugriff (PDF)

Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors

Cancer research (Chicago, Ill.), 1995-07, Vol.55 (14), p.3132-3139

1995

Volltextzugriff (PDF)

Development of a Streptavidin−Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colorectal Cancer. Studies in a Human Colon Cancer Xenograft Model

Bioconjugate chemistry, 1997-07, Vol.8 (4), p.595-604

1997

Volltextzugriff (PDF)

Advantage of a Residualizing Iodine Radiolabel for Radioimmunotherapy of Xenografts of Human Non-Small-Cell Carcinoma of the Lung

The Journal of nuclear medicine (1978), 1997-03, Vol.38 (3), p.391-395

1997

Volltextzugriff (PDF)

The Processing and Fate of Antibodies and Their Radiolabels Bound to the Surface of Tumor Cells In Vitro: A Comparison of Nine Radiolabels

The Journal of nuclear medicine (1978), 1994-05, Vol.35 (5), p.899-908

1994

Volltextzugriff (PDF)

Targeting Human Cancer Xenografts with Monoclonal Antibodies Labeled Using Radioiodinated, Diethylenetriaminepentaacetic Acid-appended Peptides

Clinical cancer research, 1999-10, Vol.5 (10), p.3079s-3087s

1999

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Humans
(28)
Mice
(27)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Oncology
(16)
Female
(13)
Mice, Nude
(13)
Pharmacology. Drug Treatments
(12)
Radioimmunotherapy
(12)
Transplantation, Heterologous
(11)
Antibodies, Monoclonal - Pharmacokinetics
(9)
Tissue Distribution
(9)
Tumor Cells, Cultured
(9)
Antigens, Differentiation, B-Lymphocyte - Immunology
(8)
Antineoplastic Agents
(8)
Lymphoma, B-Cell - Immunology
(7)
Pharmacology & Pharmacy
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Wnt/PCP controls spreading of Wnt/β-catenin signals by cytonemes in vertebrates

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms

Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist

Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists

Cure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate

Therapy of Small Subcutaneous B-Lymphoma Xenografts with Antibodies Conjugated to Radionuclides Emitting Low-Energy Electrons

Towards consensus practices to qualify safety biomarkers for use in early drug development

α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Antagonists: From Bench to Bedside

Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity

Interlaboratory Evaluation of Genomic Signatures for Predicting Carcinogenicity in the Rat

6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists

Design and Synthesis of Selective and Potent Orally Active S1P5 Agonists

Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons

Improved iodine radiolabels for monoclonal antibody therapy

Therapy of Advanced B-Lymphoma Xenografts with a Combination of 90Y-anti-CD22 IgG (Epratuzumab) and Unlabeled Anti-CD20 IgG (Veltuzumab)

Adefovir dipivoxil: A new antiviral agent for the treatment of hepatitis B virus infection

Enhancement of Tumor-to-Nontumor Localization Ratios by Hepatocyte-Directed Blood Clearance of Antibodies Labeled with Certain Residualizing Radiolabels

Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22

Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors

Development of a Streptavidin−Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colorectal Cancer. Studies in a Human Colon Cancer Xenograft Model

Advantage of a Residualizing Iodine Radiolabel for Radioimmunotherapy of Xenografts of Human Non-Small-Cell Carcinoma of the Lung

The Processing and Fate of Antibodies and Their Radiolabels Bound to the Surface of Tumor Cells In Vitro: A Comparison of Nine Radiolabels

Targeting Human Cancer Xenografts with Monoclonal Antibodies Labeled Using Radioiodinated, Diethylenetriaminepentaacetic Acid-appended Peptides

Aktive Filter

Suchergebnisse filtern